Clinical Trial Update: INR-Triggered Transfusion In GI Bleeders From ER [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating INR-triggered transfusion in adults with gastrointestinal hemorrhage has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Hemorrhage
• Liver Diseases
• Respiratory Distress Syndrome
• Transfusion-related Acute Lung Injury

Snippet

Sponsor: University of Colorado, Denver | Conditions: Respiratory Distress Syndrome, Adult, Gastrointestinal Hemorrhage | Phase 3 | Status: TERMINATED